FABRICATION OF NANO CLAY INTERCALATED POLYMERIC MICROBEADS FOR CONTROLLED RELEASE OF CURCUMIN

نویسندگان

چکیده

Objective: The objective of this study was to formulate and evaluate the Curcumin (CUR) encapsulated sodium alginate (SA)/badam gum (BG)/kaolin (KA) microbeads for controlled drug release studies.
 Methods: fabricated were characterized by fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), X-ray diffraction (X-RD), electron microscopy (SEM). Dynamic swelling studies in vitro kinetics performed simulated intestinal fluid (pH 7.4) gastric 1.2) at 37 °C.
 Results: FTIR confirms formation microbeads. DSC confirm polymorphism CUR loaded which indicate molecular level dispersion SEM confirmed are spherical shape with wrinkled rough surfaces. XRD reveal presence KA developed In depend on pH test media, might be suitable delivery. % values fit into Korsmeyer-Peppas equation n obtained range 0.577-0.664, indicates that follow non-Fickian diffusion mechanism.
 Conclusion: results concluded potentially good carriers studies.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Polymeric ocular nanosuspension for controlled release of acyclovir: in vitro release and ocular distribution

The aim of this study is to formulate a novel ophthalmic nanosuspension (ONS), an alternative carrier system to traditional colloidal carriers for controlled release (CR) of acyclovir (ACV). In the present study, ONS is employed to avoid some of major disadvantages of colloidal carriers systems such as instability in cul de sac and short half life by increasing efficiency of drug encapsulation ...

متن کامل

Polymeric ocular nanosuspension for controlled release of acyclovir: in vitro release and ocular distribution

The aim of this study is to formulate a novel ophthalmic nanosuspension (ONS), an alternative carrier system to traditional colloidal carriers for controlled release (CR) of acyclovir (ACV). In the present study, ONS is employed to avoid some of major disadvantages of colloidal carriers systems such as instability in cul de sac and short half life by increasing efficiency of drug encapsulation ...

متن کامل

Design Fabrication and Evaluation of Microbeads for Controlled Release Using Natural Polymers

Diclofenac sodium is an Non-steroidal anti-inflammatory drugs, having an elimination half-life of 1-2 hrs. The objective of the study is to prepare Diclofenac sodium Microbeaads using Natural Polymers in different concentrations. For this purpose calcium ions were used as cross linking agents in formulation of alginate-guar gumpectin, alginate-guar gum-lecithin and alginate-pectin-lecithin Micr...

متن کامل

Microfluidic fabrication of polymeric core-shell microspheres for controlled release applications.

We report a facile and robust microfluidic method to fabricate polymeric core-shell microspheres as delivery vehicles for biomedical applications. The characteristics of core-shell microspheres can be precisely and easily tuned by manipulating the microfluidic double emulsion templates. The addition of a shell can significantly improve the versatility as well as functionality of these microsphe...

متن کامل

Nano Polymeric Carrier Fabrication Technologies for Advanced Antitumor Therapy

Comparing with the traditional therapeutic methods, newly developed cancer therapy based on the nanoparticulates attracted extensively interest due to its unique advantages. However, there are still some drawbacks such as the unfavorable in vivo performance for nanomedicine and undesirable tumor escape from the immunotherapy. While as we know that the in vivo performance strongly depended on th...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: International Journal of Applied Pharmaceutics

سال: 2021

ISSN: ['0975-7058']

DOI: https://doi.org/10.22159/ijap.2021v13i1.39965